Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Sweden

Marie Skłodowska-Curie Action · Running

NEUROVISTA Neuroinflammation and Virus Imaging for Smart Therapeutic Approaches

Coordinator
Umea Universitet, Sweden
Runs
1 September 2027 to 31 August 2029
Status
Running
EU funding
€236k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101285007

What the project is doing

In the project's own words, from its summary on CORDIS.

NEUROVISTA (Neuroinflammation and Virus Imaging for Smart Therapeutic Approaches) aims to elucidate the mechanisms of HSV-1-induced neuroinflammation and evaluate nanoparticle-based therapeutic strategies using advanced whole-brain imaging. HSV-1 is a neurotropic virus linked to herpes simplex encephalitis and potentially to neurodegenerative diseases such as Alzheimer’s. Current treatments are limited by poor blood-brain barrier penetration and lack of tools to visualize viral spread and inflammation in vivo.

This project integrates virology, nanomedicine, neuroscience, and imaging across three objectives: (O1) mapping HSV-1 distribution and neuroinflammation using light sheet fluorescence microscopy (LSFM) and optical projection tomography (OPT); (O2) developing antiviral-loaded bovine serum albumin nanoparticles (BSA-NP) incorporating carrageenans; and (O3) testing nanoparticle efficacy in cellular and animal models. NEUROVISTA combines human-relevant neural models (SH-SY5Y), in vivo mouse models, and high-resolution imaging to generate quantitative datasets on viral tropism, neuroinflammatory markers, and therapeutic impact.

The fellowship will train the researcher in BSL-3 virology, advanced microscopy, and data analysis, while promoting two-way knowledge exchange with the host lab. Results will be disseminated through open-access publications, international conferences, and public engagement activities. NEUROVISTA contributes to European priorities in translational neuroscience, infection biology, and therapeutic innovation, offering a novel interdisciplinary platform to study virus-induced neurodegeneration and develop targeted interventions.

Topics

Who is involved

OrganisationCityCountryRole
Umea UniversitetUmeaSwedenCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI